Nuventra provides our clients with a deep understanding of what their drug does to a body and what a body does to their drug. Our ability to translate complex PK/PD analyses into actionable insights across the entire drug development spectrum and in every major therapeutic area is what makes us unique. We enable our clients to make better strategic decisions and improve their clinical and nonclinical study designs. Our specialized focus also helps our clients avoid costly missteps in their development programs and can increase their chances for faster regulatory authorization.

Founded in 2008, Nuventra is home to the largest collection of PK/PD experts in the industry, many of whom have 15-30 years of experience. We operate a flexible business structure that enables our consultants to quickly & seamlessly integrate with our clients’ R&D groups and become trusted, hands-on extensions of their teams. Our team is supported by robust corporate infrastructure, proven processes, innovative technology solutions, and validated SOPs.

'Darwin' Genetic Algorithm for PopPK

Automated PopPK model selection via computer algorithm...named 'Darwin for NONMEM'...saves time and money.
Learn More


Using 'Concentration-QT’ PK/PD Analysis to Eliminate the need for a Thorough QT Study. Learn More


A common sense approach based on scientific principles to provide excellence in pharmacokinetics.
Learn More

Virtual PK Group

Senior level consultants provide expert services to companies lacking pharmacokinetic and clinical pharmacology expertise in-house.
Learn More


  • Nuventra pharmacometricians and PK experts are very personable and enjoyable to work with; they make themselves available at moment’s notice. They provide excellent advice and have shown the ability to be flexible with requests.
    Sr. Director of Clinical Pharmacology, Public Biopharmaceutical Company
  • Nuventra stepped in to develop a model to define the circadian variation of an endogenous ligand and its effect on the PK of a new molecule. Our team enjoys working with Nuventra because of the attention to our needs and timelines.  Nuventra puts in the extra effort to make sure study report timelines are met.
    Chief Medical Officer of Rockwell Medical, Inc.
  • "I have enjoyed working with you all these years. It is us who have benefited from your vast and deep experience. Thanks for being a good friend to our initiatives. We will have a few more together."
    CEO of Pharma Client
  • "This IND was written quite well and is a pleasure to read. Most interesting and novel."
    FDA Medical Reviewer: response to literature-based IND written by Nuventra

The Nuventra Advantage

  • Consultants

    Only Nuventra has invested in building a consulting team made up of the largest & best collection of PK/PD experts in the world each with 15-30 years of experience.
  • Experience

    The range of our consulting services is broad & extensive and yet focused; we focus our industry-leading PK/PD lens across the entire drug development spectrum and in every major therapeutic area.
  • Structure

    We operate a flexible business structure that enables our consultants to quickly & seamlessly partner with our clients’ R&D groups and become trusted, hands-on extensions of their teams.
  • Infrastructure

    Our consultants are supported by our validated infrastructure, innovative technology solutions, and robust SOP.